EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liquid chromatography–tandem mass spectrometry for determination of fingolimod and its active metabolite fingolimod phosphate in whole blood of patients with multiple sclerosis

Veronika Pesakova iD, Hana Brozmanova, Pavel Sistik, Zuzana Kusnirikova, Ivana Kacirova, Milan Grundmann

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Veronika Pesakova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Hauptthemen laut MEDLINE: Fingolimod Hydrochloride, Tandem Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth, and Sports of the Czech Republic, University Hospital Ostrava.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fingolimod is an oral drug for the escalation of treatment of relapsing–remitting multiple sclerosis in patients with persistent disease activity on first‐line drugs or in patients with rapidly progressive severe relapsing–remitting multiple sclerosis. An ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for determining the concentrations of fingolimod and its active metabolite fingolimod phosphate in whole blood has been developed and validated. The advantages of this method are the easy, fast and cheap sample preparation using protein precipitation from blood with a mixture of acetonitrile–methanol (40:60, v/v). Chromatographic separation was performed on a ultra‐high performance liquid chromatography BEH C 18 1.7 μm (100 × 2.1 mm) column. Two modes of ionization, electrospray ionization and atmospheric pressure chemical ionization, were tested and compared. For validation, the electrospray ionization mode was chosen. As internal standard, isotopically labeled fingolimod‐D 4 was used to quantify the analytes. The method was validated according to the rules of the European Medicines Agency. The coefficients of variation for fingolimod were in the range of 1.13–11.88%, and the recovery was 98.80–106.00%. The coefficients of variation for fingolimod phosphate were in the range of 2.73–9.31%, and the recovery was 90.08–107.00%. The method is quite easy and fast and can be used for routine analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fingolimod HydrochlorideTandem Mass SpectrometryHumansReproducibility of ResultsLinear ModelsChromatography, High Pressure LiquidMultiple SclerosisFemaleMaleAdultImmunosuppressive AgentsLimit of DetectionChromatography, Liquid

Stichwörter der Autor:innen

fingolimodfingolimod phosphateliquid chromatographymass spectrometrymultiple sclerosis

Substanzen

Fingolimod HydrochlorideImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
  • Department of Children Neurology, Department of Neurology, University Hospital Ostrava, Ostrava, Czech Republic.

ORCID-Profile: Veronika Pesakova

Förderung

  • Ministry of Education, Youth, and Sports of the Czech Republic
  • University Hospital Ostrava

Zitieren

APA

Pesakova, V., Brozmanova, H., Sistik, P., Kusnirikova, Z., Kacirova, I., & Grundmann, M. (2024). Liquid chromatography–tandem mass spectrometry for determination of fingolimod and its active metabolite fingolimod phosphate in whole blood of patients with multiple sclerosis. Biomedical Chromatography. https://doi.org/10.1002/bmc.5947

Vancouver

Pesakova V, Brozmanova H, Sistik P, Kusnirikova Z, Kacirova I, Grundmann M. Liquid chromatography–tandem mass spectrometry for determination of fingolimod and its active metabolite fingolimod phosphate in whole blood of patients with multiple sclerosis. Biomedical Chromatography. 2024. doi:10.1002/bmc.5947

BibTeX
@article{Pesakova2024,
  author = {Pesakova, Veronika and Brozmanova, Hana and Sistik, Pavel and Kusnirikova, Zuzana and Kacirova, Ivana and Grundmann, Milan},
  title = {Liquid chromatography–tandem mass spectrometry for determination of fingolimod and its active metabolite fingolimod phosphate in whole blood of patients with multiple sclerosis},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5947}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche